openPR Logo
Press release

Insulin-like Growth Factors Market Top Players - Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Ascendis Pharma, Regulaxis SAS, MedImmune, LLC.

12-06-2024 07:38 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd

Insulin-like Growth Factors Market

Insulin-like Growth Factors Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Insulin-like Growth Factors Market"- By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), Industry Trends, and Global Forecasts, 2022-2035 And Segment Revenue and Forecast To 2031."

The Insulin-like Growth Factors Market is valued at US$ 275.1 Mn in 2023, and it is expected to reach US$ 406.1 Mn by 2031, with a CAGR of 5.13% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2561

A protein made by the body that stimulates the growth of many types of cells. Insulin-like growth factor is similar to insulin (a hormone made in the pancreas). There are two forms of insulin-like growth factor called IGF-1 and IGF-2. The name insulin-like growth factor reflects the fact that these substances exhibit insulin-like actions in certain tissues, although they are far less potent than insulin in reducing blood glucose concentrations. Their primary function is to stimulate growth. While IGFs share this growth-stimulating capability with other growth factors, such as epidermal growth factor, platelet-derived growth factor, and nerve growth factor, IGFs are unique because they are the only growth factors with well-documented endocrine actions in humans.

IGFs are crucial for normal growth and development, particularly during childhood and adolescence. They stimulate the growth of bones and tissues, ensuring proper physical development. IGFs play a significant role in muscle growth and repair. They enhance protein synthesis and muscle cell proliferation, making them important for muscle recovery and strength. IGF-1, in particular, is essential for bone growth and density. It helps in the formation of new bone tissue and maintains bone strength, reducing the risk of fractures and osteoporosis.

List of Prominent Players in the Insulin-like Growth Factors Market
• Boehringer Ingelheim International GmbH
• Genervon Biopharmaceuticals LLC
• Ascendis Pharma
• Regulaxis SAS
• MedImmune, LLC
• Other Prominent Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers:
The rising incidence of chronic diseases such as diabetes, cancer, and growth hormone deficiencies necessitate the use of IGF-based therapies. IGFs are used to manage these conditions, driving market demand. The expanding fields of regenerative medicine and anti-aging therapies utilize IGFs for their ability to promote cell growth and tissue repair. This broadens the market for IGF applications beyond traditional medical treatments. Increasing health awareness and changing lifestyles that prioritize fitness and well-being contribute to the demand for IGF supplements and therapies. IGFs are recognized for their role in enhancing muscle growth and overall health.

Challenges:
The potential side effects and safety concerns associated with IGF therapies, such as an increased risk of cancer and other adverse effects, can limit their adoption. Ensuring the long-term safety of these treatments is crucial for market acceptance. Despite extensive research, the complete understanding of IGF mechanisms and their interactions with other biological pathways is still limited. This can hinder the development of targeted therapies and their effectiveness.

Regional Trends:
North America has a growing geriatric population. As people age, their levels of growth factors decline. IGFs are being investigated as a potential therapy to combat the effects of aging, which could be a significant market driver in the region. North America boasts a well-established research infrastructure with leading universities and pharmaceutical companies. This fosters innovation and development in the field of IGF research.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2561

Recent Developments:
• In Aug 2021, Ascendis Pharma A/S, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11.5 kg (25.4 lb) and have growth failure due to inadequate secretion of endogenous growth hormone (GH). The company uses its novel TransCon technologies to potentially create new treatments that make a meaningful difference in patients' lives.
• In January 2024, Ascendis Pharma A/S, After reaching an exclusive distribution agreement with Danish business Ascendis Pharma A/S (NASDAQ: ASND), Specialized Therapeutics Asia Pte Ltd (ST), an independent biopharmaceutical company, has expanded its portfolio to include three novel endocrinology medicines. The agreement states that ST will market Ascendis Pharma's weekly injectable pediatric human growth hormone treatment, SKYTROFATM (lonapegsomatropin), YORVIPATHTM (palopegteriparatide), for hypoparathyroidism, and TransConTM CNP (navepegritide), an investigational treatment for achondroplasia.

Segmentation of Insulin-like Growth Factors Market.
Global Insulin-like Growth Factors Market, By Type
• Mechano Growth Factor
• Somatomedin C
• IGF 1
Global Insulin-like Growth Factors Market - By End-user
• Hospitals
• Medical Centers
Global Insulin-like Growth Factors Market - By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2561

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin-like Growth Factors Market Top Players - Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Ascendis Pharma, Regulaxis SAS, MedImmune, LLC. here

News-ID: 3775182 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
"Biocides Market" in terms of revenue was estimated to be worth $11.57 billion in 2023 and is poised to reach $16.83 billion by 2031, growing at a CAGR of 4.91% from 2024 to 2031, according to a new report by InsightAce Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1637 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Biocides Market are: • Growing Awareness of Hygiene and
Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Beneficial Insects Market Size, Share & Trends Analysis Report By Application (Crop protection, Crop production), Type (Predators, Parasitoids, Pathogens, and Pollinators), Crop Type (Fruits & Vegetables, Flowers & Ornamentals, and Grains & Pulses), Region, Market Outlook And Industry Analysis 2031" The global Beneficial Insects market is estimated to reach over USD 2.18 billion by 2031, exhibiting
Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
The global avocado puree market is estimated to reach over USD 755.03 million by 2031, exhibiting a CAGR of 5.18% during the forecast period. Fresh avocados mashed, puréed, pressed, or sieved into a creamy slurry or paste consistency are used to make avocado purees. Avocado purees make mixed fruit drinks, infant food, and guacamole. Avocado puree market revenue is predicted to increase at a high CAGR, driven by millennials' phenomenal demand
Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 2024 to 2031
Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market

All 5 Releases


More Releases for IGF

Nutura Wellness's Deer Antler Velvet Creating Buzz In Supplements Market
Nutura Wellness's Deer Antler Velvet has been successful in creating buzz in the supplement market. A lot of news suggests that Deer velvet supplements (https://nuturawellness.com/products/deer-antler-velvet-growth-factors) from Nutura have been immensely beneficial in proper brain functioning and this has seemed to work for many consumers. A new blend of supplements are infused into the market quite often recently but not all of them are very successful and misleading people into buying
Insulin Like Growth Factor (IGF) Inhibitor Market 2020 Enhancement in Medical Se …
Insulin Like Growth Factor (IGF) Inhibitor -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Insulin Like Growth Factor (IGF) Inhibitor Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has
Insulin Like Growth Factor 1 (IGF-1) Activators Market 2020 Clinical Aspects to …
Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Insulin Like Growth Factor 1 (IGF-1) Activators Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus
Global Acromegaly and Gigantism Drugs Market Report 2018 : Overview, Application …
Researchmoz added Most up-to-date research on "Global Acromegaly and Gigantism Drugs Sales Market Report 2018" to its huge collection of research reports. This report studies the global Acromegaly and Gigantism Drugs market status and forecast, categorizes the global Acromegaly and Gigantism Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H2 2017”. Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Insulin-like growth factor 2 (IGF-2) is a protein hormone. IGF-2 is influenced by placental lactogen and plays
NantCell receives FDA orphan drug status for Ganitumab Monoclonal Antibody Thera …
NantCell, Inc., part of the NantWorks ecosystem of companies, has been granted orphan drug designation from US Food and Drug Administration (FDA) for the company’s Ganitumab, Insulin Growth Factor-1R (IGF-1R) Monoclonal Antibody Therapy for the treatment of Ewing Sarcoma. Ganitumab is a fully human monoclonal antibody directed against IGF-1R that is being investigated in a Phase III human clinical trial. Mechanism of action of the monoclonal antibody is described as IGF-1R